Journal Article
. 2017 Dec; 8(58):98360-98370.
doi: 10.18632/oncotarget.21312.

Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma

Gang Liu 1 Chuanpeng Dong 1 Xing Wang 1 Guojun Hou 2 Yu Zheng 1 Huilin Xu 1 Xiaohui Zhan 3 Lei Liu 1 
Affiliations
  • PMID: 29228695
  •     49 References
  •     4 citations

Abstract

Clinical and pathological indicators are inadequate for prognosis of stage II and III colorectal carcinoma (CRC). In this study, we utilized the activity of regulatory factors, univariate Cox regression and random forest for variable selection and developed a multivariate Cox model to predict the overall survival of Stage II/III colorectal carcinoma in GSE39582 datasets (469 samples). Patients in low-risk group showed a significant longer overall survival and recurrence-free survival time than those in high-risk group. This finding was further validated in five other independent datasets (GSE14333, GSE17536, GSE17537, GSE33113, and GSE37892). Besides, associations between clinicopathological information and risk score were analyzed. A nomogram including risk score was plotted to facilitate the utilization of risk score. The risk score model is also demonstrated to be effective on predicting both overall and recurrence-free survival of chemotherapy received patients. After performing Gene Set Enrichment Analysis (GSEA) between high and low risk groups, we found that several cell-cell interaction KEGG pathways were identified. Funnel plot results showed that there was no publication bias in these datasets. In summary, by utilizing the regulatory activity in stage II and III colorectal carcinoma, the risk score successfully predicts the survival of 1021 stage II/III CRC patients in six independent datasets.

Keywords: colorectal cancer; model; prognosis; transcription factor.

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, +8 authors, Jill P Mesirov.
Proc Natl Acad Sci U S A, 2005 Oct 04; 102(43). PMID: 16199517    Free PMC article.
Highly Cited.
The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Amira Arfaoui Toumi, Olfa El Amine El Hadj, +5 authors, Saadia Bouraoui.
Appl Immunohistochem Mol Morphol, 2009 Dec 04; 18(2). PMID: 19956069
HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions.
Luiz A Bovolenta, Marcio L Acencio, Ney Lemke.
BMC Genomics, 2012 Aug 21; 13. PMID: 22900683    Free PMC article.
Highly Cited.
High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Hong-Tu Zheng, De-Bing Shi, +6 authors, San-Jun Cai.
Int J Clin Exp Pathol, 2014 Jul 18; 7(6). PMID: 25031737    Free PMC article.
Highly Cited.
Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
D J Mole, C O'Neill, +6 authors, F C Campbell.
Br J Cancer, 2011 Feb 24; 104(6). PMID: 21343932    Free PMC article.
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
D E Stange, F Engel, +9 authors, B Radlwimmer.
Gut, 2010 May 19; 59(9). PMID: 20479215
SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression.
Qiuyue Yan, Guohua Lou, +5 authors, Xuejun Dong.
Onco Targets Ther, 2016 Apr 05; 9. PMID: 27042099    Free PMC article.
Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression.
Tao Wu, Yi Li, +5 authors, Xilin Du.
J Surg Oncol, 2011 Jun 10; 104(7). PMID: 21656525
CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.
Yi-Wen Chang, Ching-Feng Chiu, +8 authors, Jen-Liang Su.
Am J Respir Crit Care Med, 2015 Apr 24; 192(1). PMID: 25906011
NME1 and NME2 as markers for myeloid leukemias.
Jessica K Altman, Leonidas C Platanias.
Leuk Lymphoma, 2012 Apr 18; 53(8). PMID: 22506600
Prognostic potential of DNA methylation and transcript levels of HIF1A and EPAS1 in colorectal cancer.
Agnieszka Anna Rawłuszko-Wieczorek, Karolina Horbacka, +2 authors, Paweł Piotr Jagodziński.
Mol Cancer Res, 2014 May 16; 12(8). PMID: 24825851
Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.
Taiki Masuda, Toshiaki Ishikawa, +7 authors, Kenichi Sugihara.
Int J Oncol, 2016 Jan 20; 48(3). PMID: 26783118    Free PMC article.
Random survival forests for competing risks.
Hemant Ishwaran, Thomas A Gerds, +3 authors, Bryan M Lau.
Biostatistics, 2014 Apr 15; 15(4). PMID: 24728979    Free PMC article.
Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Wenjun Chang, Xianhua Gao, +14 authors, Guangwen Cao.
Gut, 2013 Nov 01; 63(9). PMID: 24173294
NANOG modulates stemness in human colorectal cancer.
J Zhang, L A Espinoza, +6 authors, J M Jessup.
Oncogene, 2012 Oct 23; 32(37). PMID: 23085761    Free PMC article.
Validation techniques for logistic regression models.
M E Miller, S L Hui, W M Tierney.
Stat Med, 1991 Aug 01; 10(8). PMID: 1925153
Relationship between TP73 polymorphism (G4C14-A4T14) and cancer risk: a meta-analysis based on literatures.
Xiao-Jia Yu, Fang Fang, Jun Xie.
Gene, 2011 Jun 16; 484(1-2). PMID: 21672615
EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages.
N Mohammed, M Rodriguez, +10 authors, F Bonilla.
Oncol Lett, 2012 Aug 01; 2(4). PMID: 22848255    Free PMC article.
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.
Nicole Beauchemin, Azadeh Arabzadeh.
Cancer Metastasis Rev, 2013 Aug 02; 32(3-4). PMID: 23903773
Highly Cited. Review.
Growth factor independence 1 (Gfi1) as a regulator of p53 activity and a new therapeutical target for ALL.
Cyrus Khandanpour, Tarik Möröy.
Oncotarget, 2013 Mar 27; 4(3). PMID: 23528269    Free PMC article.
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.
Ramon Salazar, Paul Roepman, +16 authors, Rob Tollenaar.
J Clin Oncol, 2010 Nov 26; 29(1). PMID: 21098318
Highly Cited.
The clinical perspectives of CDX2 expression in colorectal cancer: a qualitative systematic review.
J Olsen, M L M Espersen, +2 authors, J T Troelsen.
Surg Oncol, 2014 Aug 16; 23(3). PMID: 25126956
Systematic Review.
Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, +6 authors, Jie He.
CA Cancer J Clin, 2016 Jan 26; 66(2). PMID: 26808342
Highly Cited.
Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Gabriella M Anic, Stephanie J Weinstein, +2 authors, Demetrius Albanes.
PLoS One, 2014 Jul 19; 9(7). PMID: 25036524    Free PMC article.
TEAD1 enhances proliferation via activating SP1 in colorectal cancer.
Min-Hao Yu, Wei Zhang.
Biomed Pharmacother, 2016 Oct 25; 83. PMID: 27434865
MiR-320e is a novel prognostic biomarker in colorectal cancer.
L Perez-Carbonell, F A Sinicrope, +5 authors, A Goel.
Br J Cancer, 2015 Jun 03; 113(1). PMID: 26035698    Free PMC article.
Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, +3 authors, Ahmedin Jemal.
CA Cancer J Clin, 2015 Feb 06; 65(2). PMID: 25651787
Highly Cited.
HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.
Yoshifumi Baba, Katsuhiko Nosho, +7 authors, Shuji Ogino.
Am J Pathol, 2010 Apr 07; 176(5). PMID: 20363910    Free PMC article.
Nanog: a potential biomarker for liver metastasis of colorectal cancer.
Feng Xu, Chaoliu Dai, +3 authors, Changjun Jia.
Dig Dis Sci, 2012 May 09; 57(9). PMID: 22562535
pROC: an open-source package for R and S+ to analyze and compare ROC curves.
Xavier Robin, Natacha Turck, +4 authors, Markus Müller.
BMC Bioinformatics, 2011 Mar 19; 12. PMID: 21414208    Free PMC article.
Highly Cited.
Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
Xiaoling Tian, Guoxiong Xu.
BMJ Open, 2015 Oct 02; 5(9). PMID: 26423854    Free PMC article.
Systematic Review.
E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis.
Andrea Buda, Massimo Pignatelli.
Cell Commun Adhes, 2011 Dec 20; 18(6). PMID: 22176698
Review.
Survival Analysis with Multiple Causes of Death: Extending the Competing Risks Model.
Margarita Moreno-Betancur, Hamza Sadaoui, Clara Piffaretti, Grégoire Rey.
Epidemiology, 2016 Jul 01; 28(1). PMID: 27362647
The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells.
Mugdha Patki, Venkatesh Chari, +3 authors, Manohar Ratnam.
J Biol Chem, 2013 Feb 22; 288(16). PMID: 23426362    Free PMC article.
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Paul A Northcott, Catherine Lee, +76 authors, Stefan M Pfister.
Nature, 2014 Jul 22; 511(7510). PMID: 25043047    Free PMC article.
Highly Cited.
Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer.
Hui-Min Meng, Ping Zheng, +6 authors, Jianming Li.
Cancer Biol Ther, 2009 Dec 23; 9(4). PMID: 20026903
-Long noncoding RNA HOTTIP as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis.
Zhicong Chen, Anbang He, +2 authors, Weiren Huang.
Oncotarget, 2016 Nov 03; 8(8). PMID: 27806342    Free PMC article.
Systematic Review.
A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients.
Seon-Kyu Kim, Seon-Young Kim, +4 authors, Jin Cheon Kim.
Mol Oncol, 2014 Jul 23; 8(8). PMID: 25049118    Free PMC article.
Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.
Hiromichi Ito, Qianxing Mo, +10 authors, Michael D'Angelica.
PLoS One, 2013 Dec 18; 8(12). PMID: 24339954    Free PMC article.
Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.
Sarah Miller, Nobel Bhasin, +4 authors, Nick M Makridakis.
Int J Oncol, 2013 Jan 08; 42(2). PMID: 23291911    Free PMC article.
NME2 reduces proliferation, migration and invasion of gastric cancer cells to limit metastasis.
Yan-fei Liu, Aijun Yang, +6 authors, Min Li.
PLoS One, 2015 Feb 24; 10(2). PMID: 25700270    Free PMC article.
STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer.
Andrew V Nguyen, Yuan-Yuan Wu, Elaine Y Lin.
World J Gastroenterol, 2014 Aug 19; 20(30). PMID: 25132744    Free PMC article.
Review.
GFI1 as a novel prognostic and therapeutic factor for AML/MDS.
J M Hönes, L Botezatu, +24 authors, C Khandanpour.
Leukemia, 2016 Feb 06; 30(6). PMID: 26847026
Metastatic colorectal cancer: current state and future directions.
Marwan G Fakih.
J Clin Oncol, 2015 Apr 29; 33(16). PMID: 25918280
Highly Cited. Review.
The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey.
John P A Ioannidis, Thomas A Trikalinos.
CMAJ, 2007 Apr 11; 176(8). PMID: 17420491    Free PMC article.
Highly Cited.
Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
Rebeca Sanz-Pamplona, Antoni Berenguer, +11 authors, Victor Moreno.
PLoS One, 2012 Nov 13; 7(11). PMID: 23145004    Free PMC article.
Systematic Review.
Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma.
Jialu Li, Yang Liu, +12 authors, Yi Ba.
Sci Rep, 2015 Aug 08; 5. PMID: 26250939    Free PMC article.
ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Takashi Kawahara, Hasanain Khaleel Shareef, +6 authors, Hiroshi Miyamoto.
Oncotarget, 2015 Sep 06; 6(30). PMID: 26342199    Free PMC article.
The Hippo pathway in colorectal cancer.
Piotr M Wierzbicki, Agnieszka Rybarczyk.
Folia Histochem Cytobiol, 2015 Jul 15; 53(2). PMID: 26160682
Review.
Twenty Metabolic Genes Based Signature Predicts Survival of Glioma Patients.
Wenfang Xu, Zhenhao Liu, +5 authors, Lei Liu.
J Cancer, 2020 Jan 04; 11(2). PMID: 31897239    Free PMC article.
Integrative analysis from multi-centre studies identifies a function-derived personalized multi-gene signature of outcome in colorectal cancer.
Jie Sun, Hengqiang Zhao, +4 authors, Meng Zhou.
J Cell Mol Med, 2019 May 30; 23(8). PMID: 31140730    Free PMC article.
Identification of predictive factors in hepatocellular carcinoma outcome: A longitudinal study.
Huiyuan Tian, Shaofeng Cao, +4 authors, Tao Qin.
Oncol Lett, 2020 Jun 23; 20(1). PMID: 32566003    Free PMC article.
Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.
Jiannan Liu, Chuanpeng Dong, +3 authors, Huanmei Wu.
BMC Med Genomics, 2020 Sep 23; 13(Suppl 9). PMID: 32957968    Free PMC article.